Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antioxidant gene expression refers to the transcriptional and translational regulation of genes encoding antioxidant enzymes and proteins that protect cells from oxidative damage caused by reactive oxygen species (ROS) and other free radicals. Key genes include superoxide dismutases (SOD1, SOD2, SOD3), glutathione peroxidases (GPX1, GPX3), catalase (CAT), and peroxiredoxins (PRDX2). Regulation is primarily at the transcriptional level, often involving the Antioxidant Response Element (ARE) and Nrf2 transcription factor. Altered expression is implicated in various diseases, including cancer and oxidative stress-related conditions. Modulating antioxidant gene expression holds therapeutic potential, but safety concerns regarding cancer promotion must be considered.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antioxidant Gene Expression (N/A).